Aizon Execute logo

Aizon Execute

Electronic batch record for pharma manufacturing with AI-driven insights, GMP compliance, and digital conversion in 6 weeks.

Solution by Aizon
Visit website

Overview

Aizon Execute is an Electronic Batch Record (eBR) solution designed for pharmaceutical manufacturing. It targets pharma companies looking to transition from paper-based batch records to digital, data-driven operations, with a stated implementation timeline of six weeks covering full integration, conversion, and GxP validation. The product is positioned around reducing deviations, accelerating batch release, and enabling review by exception through what Aizon calls Intelligent Batch Records (iBR).

The platform is built to support the full master recipe digitization journey, accommodating companies at different stages — from entirely paper-based operations through to insights-driven manufacturing on the shop floor. Euroapi's CEO has noted that the tool is designed as a lightweight, purpose-oriented eBR that reflects the realities of active pharmaceutical ingredient (API) manufacturing.

Digitization and Master Batch Record Creation

  • Supports automated digitization of paper-based Master Batch Records (MBR) with automated phase identification to accelerate the conversion process.
  • Operates within a fully GMP and ALCOA+ compliant environment, incorporating workflows, rule enforcement, and human validation steps.
  • Provides an intuitive GMP environment designed to reduce the effort required to verify electronic MBRs (eMBRs), aiming for frictionless compliance.
  • Does not require MES engineers to configure or operate, distinguishing it from traditional paper-on-glass approaches.

Batch Execution and Operations

  • Offers a recipe-driven user interface with a familiar look and feel, intended to minimise operator training requirements.
  • Includes simple change management tools with a modern UX built specifically for pharma manufacturing workflows.
  • Provides business continuity protections against network disruptions and other adverse events during batch execution.
  • Supports pharma operations natively, including automatic event creation and electronic signatures (e-signatures).

Data Access, Batch Release, and Audit Readiness

  • Gives manufacturers ownership of their production data and facilitates its availability across systems and sites in real time.
  • Supports review by exception to accelerate batch release processes.
  • Generates automated reports and maintains intuitive audit trails to support audit readiness.
  • Delivers real-time, AI-generated insights on the shop floor to support yield improvement, shorter cycle times, and Right First Time process execution.

Aizon Execute is targeted at pharmaceutical manufacturing sites seeking a GxP-validated digital solution that can be deployed rapidly. The platform is designed to integrate with existing systems and facilitate data availability across multiple sites, supporting broader data-driven manufacturing initiatives.

Meta

Domain
Manufacturing & Bioprocessing
Subdomain
Manufacturing Execution Systems (MES)
Software type(s)
Record-Keeping System
Deployment type(s)
Cloud / SaaS
Industry vertical(s)
PharmaBiotechCRO
Development stage(s)
Manufacturing
Target user(s)
QA / Regulatory AffairsAutomation EngineerIT / Systems Admin / Data Engineer
Compliance standard(s)
21 CFR Part 11GxP
Tag(s)
Uses AI